All News Synairgen plc

Equities

Market Closed - London S.E. Other stock markets 11:35:17 2024-05-08 am EDT			5-day change	1st Jan Change
5.76 ^GBX	-2.54%		-7.69%	-3.60%

May. 07	AstraZeneca target raised; Antofagasta lowered	AN
2023	FTSE 100 Finishes Slightly Lower After Steady Session	DJ

AstraZeneca target raised; Antofagasta lowered	May. 07	AN
Synairgen : IDWeek 2023 Poster Presentation	23-10-12	PU
FTSE 100 Finishes Slightly Lower After Steady Session	23-10-11	DJ
Synairgen names Phytome's Joseph Colliver as CFO	23-10-11	AN
Biotech Company Synairgen Names New CFO	23-10-11	MT
Synairgen plc Announces Executive Changes	23-10-11	CI
Synairgen plc Announces Board Changes	23-10-11	CI
Synairgen promotes Marcin Mankowski to chief medical officer	23-10-03	AN
Synairgen plc Announces Appointment of Dr. Marcin Mankowski as Chief Medical Officer	23-10-03	CI
Synairgen narrows interim loss on reduced R&D spending	23-09-21	AN
Synairgen looking beyond COVID in fight against respiratory illness	23-09-21	AQ
Synairgen : Interim Results	23-09-21	PU
Earnings Flash (SNG.L) SYNAIRGEN Posts H1 Loss GBX-2.36	23-09-21	MT
Synairgen plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-21	CI
Synairgen : ATS 2023 SPRINTER Poster Presentation	23-05-23	PU
Synairgen : 2022 Annual Report	23-05-23	PU
Synairgen CEO lays out plans for 2023 and beyond	23-04-28	AQ
Synairgen loss narrows; aims to develop SNG001	23-04-27	AN
Earnings Flash (SNG.L) SYNAIRGEN Reports FY22 Loss GBX-8.76	23-04-27	MT
Synairgen plc Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI

No results for this search